Important new FDA labeling information about managing opioid pain medications

FDA addresses danger of abruptly ending opioids and clarifies its position for providers

Read the specifics of the FDA announcement at the following FDA links.

FDA Press Statement - https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm635640.htm

FDA Drug Safety Communication - https://www.fda.gov/Drugs/DrugSafety/ucm635038.htm